Next generation of innovative antigen-specific immune therapies for autoimmune diseases
TOLERATE is a Doctoral Network (DN) funded by the European Union Horizon Europe Programme. TOLERATE aims at training Doctoral Candidates (DCs) to acquire the skills to develop different innovative strategies to treat autoimmune diseases, to identify the most promising strategies or a combination of strategies, to setup clinical trials and to develop a roadmap to bring a novel therapeutic agent to the market.
A highly innovative research programme focused on the orphan autoimmune disease iTTP
Training next generation of highly skilled professionals with the expertise and skills to decrease the burden of autoimmune disease in Europe
Providing a solid understanding on novel therapies for autoimmune diseases and the importance of long-term follow-up of patients